From: Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
Study | Study design | Site of infection | Drugs used in eradication phase | Dose | Duration | Side effects | Outcomes |
---|---|---|---|---|---|---|---|
Saravu et. al. [40] | Case series | Case 1—liver, blood, lungs |  | Not given | Not given |  |  |
 |  | Case 2- liver, spleen, lungs, bones | Oral co-amoxiclav and Oral Co-trimoxazole | Not given | 24 weeks | Weight gain | Splenomegaly completely regressed; hip pain subsided |
 |  | Case 3-liver, spleen |  | Not given | Not given |  |  |
 |  | Case 4- liver, spleen, rain |  | Not given | Not given |  |  |
 |  | Case 5-spleen, Liver, lungs, blood |  | Not given | Not given |  | Septic shock, ARDS, death |
 |  | Case 6- mediastinum | Oral co-amoxiclav and Co-trimoxazole | Not given | Not given |  | Lost follow up |
 |  | Case 7- spleen, blood | Oral co-amoxiclav and Co-trimoxazole | Not given | 14 weeks |  | Symptoms free at 6 months |
Nandasiri et al. [41] | Case report | Spinal cord, bones, psoas abscess | Oral Co-trimoxazole oral doxycycline | Not given | 52Â weeks | Â | The residual neurological deficits including the paraplegia, complete sensory loss and sphincter disturbance persisted |
Weerasinghe et al. [42] | Case report | Bone- hip joint | Oral Co-trimoxazole | Not given | 10Â weeks | Â | Symptoms resolved |
Owen et al. [43] | Case report | Brain | Oral Co-trimoxazole | Not given | Not given | Â | Â |
Shrestha et al. [44] | Case report | Case 1—liver, soft tissues, lungs | Oral doxycycline and oral Co-trimoxazole | oral doxycycline [100 mg 12 hourly] and oral Co-trimoxazole (960 mg once daily) for three months | 12 weeks |  |  |
 |  | Case 2- spleen | Oral doxycycline and oral Co-trimoxazole |  | 12 weeks |  |  |
Karunarathna et al. [45] | Case report | Bones, soft tissues | Oral Co-trimoxazole | Â | 24Â weeks | Â | Symptoms resolved |
Martin et al. [46] | Case report | Liver | Oral Co-trimoxazole | Oral co- trimoxazole 800/160Â mg twice a day | 12Â weeks | Â | Symptoms resolved |
Phillips et al. [47] | Case report | Sinuses | Oral Co-trimoxazole (Bactrim®) | Oral co-trimoxazole (Bactrim®) 160 mg/800 mg twice daily for 14 weeks | 14 weeks |  | Culture negative for B. psuedomallei |
Mabayoje et al. [48] | Case report | Knee joint | Oral doxycycline and Oral Co-trimoxazole | Oral co-trimoxazole (960 mg 2 × /d; 160 mg of trimethoprim and 800 mg of sulfamethoxazole) and doxycycline (100 mg 2 × /d) | 8 weeks |  | Had full range of movements of the knee joints |
Huang et al. [49] | Case report | Joints, lungs | Oral Co-trimoxazole | 960Â mg tablets of oral Co-trimoxazole every 12hourly | 24Â weeks | Â | Symptoms resolved and no relapses occurred |
Jayawardena et al. [50] | Case report | Soft tissues | Oral Co-trimoxazole | Oral co-trimoxazole 960Â mg 12-hourly | 24Â weeks | Â | Symptoms resolved |
Rahim et al. [51] | Case reports | Kidney | Oral doxycycline and Oral Co-trimoxazole | Oral co-trimoxazole (960Â mg Q 12Â h) and doxycycline (100Â mg Q 12Â h) | 20Â weeks | Â | Symptoms resolved and no relapses occurred |
Zaw et al. [52] | Case report | Lungs | Oral Co-trimoxazole | Oral co-trimoxazole (800Â mg/160Â mg) 2 tablets twice a day with daily folic acid5mg | 12Â weeks | Â | Symptoms resolved |
Nair et al. [53] | Case report | Ankle joint | Oral Co-trimoxazole | Oral co-trimoxazole 160Â mg/800Â mg | 20Â weeks | Â | Normal weight bearing in 6Â months |
Soo et al. [21] | Case report | Lungs | Oral doxycycline and Oral Co-trimoxazole | oral doxycycline 100Â mg 12 hourly and three tablets of co-trimoxazole 80/400Â mg (TMP-SMX) 12hourly | 20Â weeks | Â | Symptoms resolved |
Commons et al. [54] | Case report | Lungs | Oral Co-trimoxazole | Oral co-trimoxazole 1600/320Â mg bd | 6Â weeks given (intended duration 3Â months) | Agitation, exacerbation of psoriatic skin lesions and thrush | Due to adverse effects drug changed into amoxicillin-clavulanic acid (500/125Â mg 3mane, 2 midi, 3 nocte).1The patient continued this treatment for the remaining 6Â weeks of eradication therapy. Then symptoms resolved |
Wijekoon et al. [55] | case report | Liver, spleen and CSF | Oral Co-trimoxazole and Co-amoxiclav | Oral co-trimoxazole 1920Â mg 12hourly and co-amoxiclav 625Â mg 8Â h | 12Â weeks | Â | No relapse or weakness |
Pitman et al. [67] | Case report | Brain and bones | Oral Co-trimoxazole | Oral co-trimoxazole (TMP-SMX) at the dose of 3 × 80 mg of TMP–400 mg of SMX (480 mg), every 12 h | 24 weeks |  | No Neurological deficits occurred and symptoms were resolved |
Antony et al. [56] | Case report | Central nervous system | Oral Co-trimoxazole | Oral co-trimoxazole (TMP 320Â mg/SMX1600mg) two times per day | 12Â weeks | Â | The facial palsy showed improvement |
Kuijpers et al. [57] | Case report | Skin and soft tissues | Oral Co-trimoxazole | oral trimethoprim–sulfamethoxazole 1920 mg every 12 h | 6 weeks / 3 months |  | No recurrence of the skin abscess was observed |
Ding et al. [58] | case report | Left infrarenal aortic aneurysm | Oral Co-trimoxazole and doxycycline | Co-trimoxazole (320Â mg/1600Â mg) bd and oral doxycycline 100Â mg bd | 20Â weeks | Â | Symptoms resolved |
Sachindra et al. [59] | Case report | Lungs, kidneys and brain | Oral Co-trimoxazole | Co-trimoxazole (1920Â mg 12Â hourly | 12Â weeks | Â | Resolved completely |
Redondo et al. [60] | Case report | Bones | Oral Co-trimoxazole and doxycycline | oral doxycycline (100Â mg every 12Â h) and Oral co-trimoxazole (1double strength tablet every 12Â h) | 48Â weeks | Â | Symptoms resolved |
Vaid et al. [61] | Case report | Temporomandibular joint (TMJ) | Oral Co-trimoxazole | Oral co-trimoxazole 240/1200Â mg orally twice a day | 24Â weeks | Â | Symptoms resolved |
Saonanon,et al. [62] | Case report | Case 2-Orbit | Oral Co-trimoxazole and doxycycline | Co-trimoxazole (80/400Â mg) 2 tablets 3 times a day in combination with doxycycline (100Â mg) 1 tablet twice a day | 24Â months | Â | The patient had showed no relapse, OD visual acuity was 20/30 and he had a noticeable scar on his forehead |
Lee et al. [63] | Case report | Case 1—Liver, spleen | Oral Co-trimoxazole |  | 32 months |  | No relapse for 2 years |
 |  | Case 2—Liver, spleen, prostate, lungs | Oral Co-trimoxazole | Oral Use co-trimoxazole (TMP 80 mg; SMX400 mg) two tablets every 6 h | 6 weeks |  | Patient was clinically well |
Svensson et al. [64] | Case report | Soft tissues | Oral Co-trimoxazole and doxycycline | Oral eradication therapy with doxycycline (100Â mg) and Oral Co-trimoxazole (160Â mg/800Â mg) twice daily was then started | 20Â weeks | nausea | No recurrence observed |
Shrestha et al. [65] | Case report | Lungs | Oral Co-trimoxazole (TMP/SMX) | Oral co-trimoxazole (TMP/SMX) 10Â mg/kg | 16Â weeks | Â | Symptoms resolved |
Bodilsen et al. [66] | Case report | Joints | Oral Co-trimoxazole | Oral co-trimoxazole TMP-SMX 800/160Â mg twice daily | 12Â weeks | Â | Wound healed without a scar and no history of relapse |
Behera et al. [67] | Case report | Liver, spleen, lungs and joints | Oral Co-trimoxazole (MIC < 2/38 microg/mL) | Oral co-trimoxazole (TMP/SMX) 1 double strength tablet every 12 h | 24 weeks |  | Symptoms resolved |
Saravu et al. [68] | Case report | Case 1—brain, lung, liver, spleen | Oral doxycycline and oral Co-trimoxazole | Oral co-trimoxazole 320 mg/1600 mg, twice a day and doxycycline 100 mg every 12 h | 24 weeks |  | Patient improved |
 |  | Case 2—spinal cord | Oral doxycycline and oral Co-trimoxazole | Oral co-trimoxazole 320 mg/1600 mg, twice a day and doxycycline 100 mg every 12 h | 24 weeks |  | Patient improved partially |